Clinical trial
Longitudinal Endpoint Assessment of Disease Burden in HD
NCT06475898 is registered in ClinicalTrials.gov with Huntington Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Endpoint Assessment of Disease Burden in HD
- Lead sponsor
- Huntington Study Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 25, 2024
- Completion date
- December 31, 2026
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.